Goldman also say at that time of report: "Although the market for the product is estimated to be in excess of $1 billion annually, clearly the total available market is not as great as the cold medication produced and marketed by Hensley’s former company, which generated roughly $100M in sales in the first 3 years. Nonetheless, considering the advantages, likely efficacy and innovative delivery method, we believe it will ramp up to tens of millions in annual revenue relatively quickly."
News 
Market Data 
Discover 
AI
